These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25014241)

  • 1. Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective study.
    Kessoku T; Yoneda M; Sumida Y; Eguchi Y; Fujii H; Hyogo H; Ono M; Kawaguchi T; Nakajima A;
    J Clin Gastroenterol; 2015 Feb; 49(2):169-70. PubMed ID: 25014241
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of metabolic syndrome and nonalcoholic steatohepatitis.
    Sertoglu E; Uyanik M; Kayadibi H
    J Clin Gastroenterol; 2015 Apr; 49(4):352-3. PubMed ID: 25551207
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease: A sign of systemic disease.
    Reccia I; Kumar J; Akladios C; Virdis F; Pai M; Habib N; Spalding D
    Metabolism; 2017 Jul; 72():94-108. PubMed ID: 28641788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
    Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
    Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New trends in non-alcoholic fatty liver diseases (NAFLD)].
    Barigou M; Favre L; Fraga M; Artru F
    Rev Med Suisse; 2020 Mar; 16(687):586-591. PubMed ID: 32216182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
    Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
    Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
    Seto WK; Yuen MF
    J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.
    Pasarín M; Abraldes JG; Liguori E; Kok B; La Mura V
    World J Gastroenterol; 2017 Oct; 23(37):6777-6787. PubMed ID: 29085222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.
    Andrade GC; Fujise LH; Santana JE; Oliveira F; Silva Rde C
    Rev Assoc Med Bras (1992); 2016; 62(3):218-26. PubMed ID: 27310544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases.
    Yang Y; Qi ZR; Zhang TT; Kang YJ; Wang X
    Neuro Endocrinol Lett; 2018 May; 39(2):99-104. PubMed ID: 30183204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
    Polyzos SA; Kountouras J; Mantzoros CS; Polymerou V; Katsinelos P
    Diabetes Obes Metab; 2017 Dec; 19(12):1805-1809. PubMed ID: 28452101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for bariatric surgery in patients with cirrhosis.
    Goh GB; Schauer PR; McCullough AJ
    World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and Nonalcoholic Fatty Liver Disease.
    Carrascosa JM; Bonanad C; Dauden E; Botella R; Olveira-Martín A;
    Actas Dermosifiliogr; 2017; 108(6):506-514. PubMed ID: 28318525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.